A man who discovered he had prostate cancer following a free blood test run by a volunteer group has urged other men to get ...

Alexandre Mugwaneza, 69, visited his wife’s paternal cousin, who was battling prostate cancer. The image of a once-active man now frail and bedridden stayed with him. Though Mugwaneza felt fine, that ...

2Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, New York. *Corresponding Author: Kevin Kensler, Department of Population Health Sciences, Weill Cornell Medicine, 425 East ...

Prostate cancer remains one of the most significant health concerns for men worldwide, with detection and treatment options ...

Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, has met a ...

The first patient has been enrolled in a trial evaluating ClarityDX Prostate’s impact on early prostate cancer detection, ...

Ablin agrees that many screening tests, such as mammograms for breast cancer and colonoscopies for colon cancer, are very useful. But PSA levels are not a good predictor of whether a man may have ...

There is a general consensus among clinicians that a serum prostate-specific antigen (PSA) level ≥4.0 ng/ml is predictive of prostate cancer, and necessitates a biopsy. But there is a dearth of ...

Low baseline IsoPSA index correlates with reduced risk of clinically significant prostate cancer in patients with elevated PSA levels. Patients with low IsoPSA index showed lower rates of prostate ...

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

Residual cancer after neoadjuvant therapy predicts recurrence years later in men undergoing surgery for high-risk prostate cancer.